Search research articles
Contact Us
Filters
Showing results (511-520 of 602) with videos related to
Page
of 61
Sort By:
Cancer Discovery
|
February 23, 2024
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
Eric Y Stutheit-Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, et al.
Nature Communications
|
April 3, 2024
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment
Jie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Nature Communications
|
August 30, 2024
FAM72A degrades UNG2 through the GID/CTLH complex to promote mutagenic repair during antibody maturation
Philip Barbulescu, Chetan K Chana, Matthew K Wong, et al.
NPJ Precision Oncology
|
March 12, 2024
Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition
V J Forster, M Aronson, C Zhang, et al.
Cancer Research Communications
|
June 28, 2023
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome
Vallijah Subasri, Nicholas Light, Nisha Kanwar, et al.
Genome Research
|
June 29, 2019
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Michael J Johnston, Ana Nikolic, Nicoletta Ninkovic, et al.
Cell Metabolism
|
December 8, 2021
Coenzyme A fuels T cell anti-tumor immunity
Michael St Paul, Samuel D Saibil, SeongJun Han, et al.
Elife
|
April 22, 2020
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma
Kenji Murata, Munehide Nakatsugawa, Muhammed A Rahman, et al.
Plos One
|
February 16, 2021
Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center
Victor H Ferreira, Andrzej Chruscinski, Vathany Kulasingam, et al.
Clinical Colorectal Cancer
|
July 3, 2024
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer
Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, et al.
Page
of 61
Search research articles
Search
Showing results (511-520 of 602) with videos related to
Sort By:
Page
of 61
Cancer Discovery
|
February 23, 2024
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors
Eric Y Stutheit-Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, et al.
Nature Communications
|
April 3, 2024
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment
Jie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Nature Communications
|
August 30, 2024
FAM72A degrades UNG2 through the GID/CTLH complex to promote mutagenic repair during antibody maturation
Philip Barbulescu, Chetan K Chana, Matthew K Wong, et al.
NPJ Precision Oncology
|
March 12, 2024
Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition
V J Forster, M Aronson, C Zhang, et al.
Cancer Research Communications
|
June 28, 2023
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome
Vallijah Subasri, Nicholas Light, Nisha Kanwar, et al.
Genome Research
|
June 29, 2019
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Michael J Johnston, Ana Nikolic, Nicoletta Ninkovic, et al.
Cell Metabolism
|
December 8, 2021
Coenzyme A fuels T cell anti-tumor immunity
Michael St Paul, Samuel D Saibil, SeongJun Han, et al.
Elife
|
April 22, 2020
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma
Kenji Murata, Munehide Nakatsugawa, Muhammed A Rahman, et al.
Plos One
|
February 16, 2021
Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center
Victor H Ferreira, Andrzej Chruscinski, Vathany Kulasingam, et al.
Clinical Colorectal Cancer
|
July 3, 2024
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer
Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, et al.
Page
of 61